---
title: "12 Health Care Stocks Moving In Friday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294542254.md"
description: "In Friday's intraday session, several healthcare stocks experienced significant volatility. Gainers included Replimune Group (up 96.1%), SCYNEXIS (up 22.54%), and Shuttle Pharmaceuticals (up 19.74%). Conversely, major losers featured Karyopharm Therapeutics (down 72.5%), Nuwellis (down 63.38%), and Moleculin Biotech (down 62.36%). These movements occurred following the release of Q2 earnings reports for some companies."
datetime: "2026-07-31T17:05:49.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294542254.md)
  - [en](https://longbridge.com/en/news/294542254.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294542254.md)
---

# 12 Health Care Stocks Moving In Friday's Intraday Session

### Gainers

-   **Replimune Group** (NASDAQ:REPL) stock rose 96.1% to $10.61 during Friday's regular session.
-   **SCYNEXIS** (NASDAQ:SCYX) stock moved upwards by 22.54% to $4.57. The market value of their outstanding shares is at $37.0 million.
-   **Shuttle Pharmaceuticals** (NASDAQ:SHPH) shares moved upwards by 19.74% to $3.7. The market value of their outstanding shares is at $1.8 million.
-   **CareDx** (NASDAQ:CDNA) shares increased by 14.9% to $43.78. The market value of their outstanding shares is at $1.9 billion. As per the press release, Q2 earnings came out yesterday.
-   **Intelligent Bio Solutions** (NASDAQ:INBS) stock moved upwards by 14.28% to $1.8. The market value of their outstanding shares is at $3.7 million.
-   **Zentek** (NASDAQ:ZTEK) stock moved upwards by 13.89% to $0.63. The company's market cap stands at $69.8 million.

### Losers

-   **Karyopharm Therapeutics** (NASDAQ:KPTI) stock declined by 72.5% to $1.93 during Friday's regular session. The company's market cap stands at $158.8 million.
-   **Nuwellis** (NASDAQ:NUWE) stock decreased by 63.38% to $1.63.
-   **Moleculin Biotech** (NASDAQ:MBRX) stock declined by 62.36% to $0.38. The market value of their outstanding shares is at $5.4 million.
-   **Bioage Labs** (NASDAQ:BIOA) stock decreased by 61.74% to $9.51. The market value of their outstanding shares is at $1.1 billion.
-   **Myriad Genetics** (NASDAQ:MYGN) stock decreased by 46.28% to $2.88. The market value of their outstanding shares is at $507.1 million. As per the press release, Q2 earnings came out yesterday.
-   **GlucoTrack** (NASDAQ:GCTK) stock decreased by 39.56% to $0.47. The market value of their outstanding shares is at $5.1 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [MBRX.US](https://longbridge.com/en/quote/MBRX.US.md)
- [NUWE.US](https://longbridge.com/en/quote/NUWE.US.md)
- [REPL.US](https://longbridge.com/en/quote/REPL.US.md)
- [SHPH.US](https://longbridge.com/en/quote/SHPH.US.md)
- [SCYX.US](https://longbridge.com/en/quote/SCYX.US.md)
- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [CDNA.US](https://longbridge.com/en/quote/CDNA.US.md)
- [INBS.US](https://longbridge.com/en/quote/INBS.US.md)
- [ZTEK.US](https://longbridge.com/en/quote/ZTEK.US.md)
- [BIOA.US](https://longbridge.com/en/quote/BIOA.US.md)
- [MYGN.US](https://longbridge.com/en/quote/MYGN.US.md)
- [GCTK.US](https://longbridge.com/en/quote/GCTK.US.md)

## Related News & Research

- [Nuwellis Raises $3.4 Million in Registered Direct Offering; Hires Ladenburg Thalmann as Agent](https://longbridge.com/en/news/294737119.md)
- [Moleculin Biotech prices offering with warrants for 37,130,001 shares at $0.75 exercise price](https://longbridge.com/en/news/294525518.md)
- [Karyopharm grants 333 RSUs to newly hired employee under inducement plan](https://longbridge.com/en/news/294732397.md)
- [Karyopharm says Phase 3 selinexor maintenance trial in endometrial cancer misses PFS endpoint](https://longbridge.com/en/news/294410278.md)
- [Karyopharm plans August sNDA filing seeking FDA priority review for selinexor-ruxolitinib in myelofibrosis](https://longbridge.com/en/news/294411025.md)